Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics.
about
Advances in sarcoma diagnostics and treatmentEpigenetic mechanisms drive the progression of neurofibromas to malignant peripheral nerve sheath tumorsRadiation-associated neoplasia: clinical, pathological and genomic correlates.Morphological spectrum of peripheral nerve sheath tumors: An insight into World Health Organization 2013 classification.Emerging genotype-phenotype relationships in patients with large NF1 deletions.Malignant Peripheral Nerve Sheath Tumor With Divergent Glandular Differentiation.Molecular profiling of sarcomas: new vistas for precision medicine.Malignant mesenchymal neoplasms of the dermis and subcutis mimicking benign lesions: a case-based review.Histopathologic Evaluation of Atypical Neurofibromatous Tumors and Their Transformation into Malignant Peripheral Nerve Sheath Tumor in Neurofibromatosis 1 Patients - A Consensus Overview.Recurrent NTRK1 Gene Fusions Define a Novel Subset of Locally Aggressive Lipofibromatosis-like Neural Tumors.Reduced H3K27me3 Expression Is Common in Nodular Melanomas of Childhood Associated With Congenital Melanocytic Nevi But Not in Proliferative Nodules.Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival.Comparision of New Diagnostic Tools for Malignant Peripheral Nerve Sheath Tumors.The genomic landscape of malignant peripheral nerve sheath tumors: diverse drivers of Ras pathway activation.Role of Histone H3K27 Trimethylation Loss as a Marker for Malignant Peripheral Nerve Sheath Tumor in Fine-Needle Aspiration and Small Biopsy Specimens.Epigenetic Alterations in Bone and Soft Tissue Tumors.SMARCB1-deficient Tumors of Childhood: A Practical Guide.Pathology of retroperitoneal sarcomas: A brief review.TFG-MET fusion in an infantile spindle cell sarcoma with neural features.H3K27me3 immunostaining for sex determination in the context of presumed tissue misidentification.Reduced H3K27me3 expression in radiation-associated angiosarcoma of the breast.Significance of H3K27me3 loss in the diagnosis of malignant peripheral nerve sheath tumors.A Clinicopathologic Study of Head and Neck Malignant Peripheral Nerve Sheath Tumors.Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma.Low-grade Schwann cell neoplasms with leptomeningeal dissemination: clinicopathologic and autopsy findings.Immunohistochemistry for trimethylated H3K27 in the diagnosis of malignant peripheral nerve sheath tumours.H3K27me3 immunohistochemistry highlights the inactivated X chromosome (Xi) and predicts sex in non-neoplastic tissues.Loss of H3K27 trimethylation is not suitable for distinguishing malignant peripheral nerve sheath tumor from melanoma: a study of 387 cases including mimicking lesions.Altered primary chromatin structures and their implications in cancer development.Superficial malignant peripheral nerve sheath tumor with overlying intradermal melanocytic nevus mimicking spindle cell melanoma.Malignant Peripheral Nerve Sheath Tumor of the Femur: A Rare Diagnosis Supported by Complete Immunohistochemical Loss of H3K27me3.
P2860
Q28069695-37668B72-101F-4D57-A0F2-72F5F4DFC685Q28080040-151352A2-4CDE-45AC-AB8F-E64611FB9555Q30240080-7F170513-2F2B-4B89-BCCF-5CE133FAAA39Q30380389-954E7CDF-0183-46FF-A61D-8F8103602EF3Q37725901-0708C07A-8F90-4DA9-8B19-0C367C0D51F6Q38734504-8AB9993C-1246-4F5D-AAC6-DF42E00B5A5FQ39406356-52536382-C514-455C-846B-442E45CA59E6Q39429904-07FCD6E4-0374-4596-9611-4B9DF06668E0Q40182996-BF58934B-207F-4FD9-AC75-881894272D9FQ41631541-9BEF0915-8565-488B-91D0-3C021A4A2C72Q42067848-82C0B801-392F-40D8-8A2F-56937D9248AEQ42415336-EEB28A2F-B889-4C3D-A358-60D3D09F54CFQ46560151-F80C0CB7-2DF8-4473-AA1F-2C71E85F18EFQ47123485-3ACFF313-CB9C-4525-818A-2988EBFAA494Q47816353-148EFB4A-E727-4D2B-AC7C-D7843F171506Q47835503-8D72C699-11FD-47E3-8906-5DC288E6D5F1Q47894129-0C54E49E-8D9E-4ED5-B4A9-D0F3EF13BC2FQ48136499-BC0FAFEB-4775-4FA9-81AC-A185D441DA2EQ48136767-80EA59B2-AC25-4112-99DF-0E492F2BBB1BQ48192894-DF8B7808-CDA1-40B9-BD57-B97A224E4346Q48234961-63B84080-908B-4C9A-B011-8D8A82EA6802Q48292391-4BDA8CCE-D1D5-4CEB-859D-2F49028FFCBDQ48316073-4CD90FB9-E3A4-4DEC-9FD8-5FD4F4CAB0EFQ49206365-1A28F201-31EF-4C73-9EBC-59B7F432F4C8Q51463647-C16A784C-D90E-48DE-B9EE-4BCA584CD580Q51540468-F8B6FA1F-D66D-4910-901D-C4A1BD500EA8Q51701158-20DD2997-92CF-4DAB-AA67-FBB5F94A4CF2Q52561320-91B81F7F-393D-467F-A8ED-146A7870EB1CQ52878923-5D158CA4-0CD4-4651-B3CF-96BDD0DEC702Q52997620-8207DB13-AD50-44AE-A8EF-2274599FB204Q54402056-D2704ECA-174B-4843-96A6-499ECDF94230
P2860
Loss of H3K27 trimethylation distinguishes malignant peripheral nerve sheath tumors from histologic mimics.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Loss of H3K27 trimethylation d ...... tumors from histologic mimics.
@en
Loss of H3K27 trimethylation d ...... tumors from histologic mimics.
@nl
type
label
Loss of H3K27 trimethylation d ...... tumors from histologic mimics.
@en
Loss of H3K27 trimethylation d ...... tumors from histologic mimics.
@nl
prefLabel
Loss of H3K27 trimethylation d ...... tumors from histologic mimics.
@en
Loss of H3K27 trimethylation d ...... tumors from histologic mimics.
@nl
P2860
P1433
P1476
Loss of H3K27 trimethylation d ...... tumors from histologic mimics.
@en
P2093
Christopher Dm Fletcher
Inga-Marie Schaefer
P2860
P2888
P356
10.1038/MODPATHOL.2015.134
P577
2015-11-20T00:00:00Z